高鴻股份(000851.SZ):擬以3.5億元現金出資參與投設新公司開展車聯網業務
格隆匯11月3日丨高鴻股份(000851.SZ)公佈,為更好的提升自身車聯網業務綜合實力,整合內外部資源,化解多方面風險,公司擬以現金出資3.5億元,控股股東電信科學技術研究院有限公司(“電信科研院”)以及其關聯方大唐電信科技產業控股有限公司(“大唐控股”)以車聯網相關資產出資,預計約0.3億元,不超過0.5億元。(具體以評估結果為準);非關聯方投資人以現金出資,各方共同設立新公司,新公司注冊資本不超過7.2億元。
公司此次參與共同投資項目,從公司發展戰略的角度來説,此次投資為了更好的發展車聯網業務,以增強綜合實力,化解多方風險,實現車聯網業務的可持續發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.